16 Questions
What is the mechanism of action of low-dose aspirin (81mg enteric coated tablet/day)?
Inhibition of cyclooxygenase enzyme (COX-1) and thromboxane (TXA2) synthesis in platelets
What is the function of antiplatelet drugs in the context of thrombosis?
Prevent platelet aggregation and inhibit thrombus formation
What is the primary objective of thrombolytic drugs?
To dissolve or lyse existing blood clots
What is the definition of hemostasis?
The body’s process of stopping bleeding in a blood vessel
Which type of drugs dissolve blood clots that have already formed in blood vessels?
Thrombolytic drugs
What is the mechanism of action of thrombolytic drugs?
Activating plasminogen to convert it to plasmin
Which type of thrombolytic drugs can lead to unwanted systemic fibrinolysis and increased risk of bleeding?
Non-fibrin specific
What are the therapeutic uses of thrombolytic drugs?
Acute myocardial infarction
What is a significant risk factor for cardiovascular diseases, including heart disease and stroke?
Hyperlipidemia
What are the complexes of lipid and proteins known as, in which lipids are transported in plasma?
Lipoproteins
Which drug class interferes with cholesterol synthesis by inhibiting HMG-CoA reductase?
HMG-CoA reductase inhibitors (statins)
What are the adverse effects of statins?
Myalgia, rhabdomyolysis, and increased liver enzymes
Which lipid-lowering drug class activates nuclear receptors and regulates lipid metabolism?
Fibrates
What are the adverse effects of fibrates?
Gastrointestinal upset, diarrhea, and myositis
What do fibrinolytic inhibitors such as aminocaproic acid and tranexamic acid do?
Inhibit plasminogen activation and promote clot stabilization
What is a common drug interaction associated with fibrates?
Drug interactions with warfarin
Study Notes
Anticoagulants and Thrombolytics: Mechanism and Uses
- Anticoagulants prevent thrombus formation and extension, while thrombolytic drugs dissolve blood clots that have already formed in blood vessels.
- Thrombolytic drugs stimulate plasminogen activation, converting it to plasmin, which then breaks down fibrin clots into soluble derivatives.
- Types of thrombolytic drugs include non-fibrin specific (e.g., streptokinase) and fibrin specific (e.g., alteplase).
- Non-fibrin specific thrombolytics can lead to unwanted systemic fibrinolysis and increased risk of bleeding, while fibrin specific agents have a lower risk of bleeding.
- Therapeutic uses of thrombolytic drugs include acute myocardial infarction, acute ischemic stroke, and deep vein thrombosis (DVT).
- Adverse effects of thrombolytic drugs include bleeding, particularly with non-fibrin specific agents.
- Fibrinolytic inhibitors, such as aminocaproic acid and tranexamic acid, inhibit plasminogen activation and promote clot stabilization.
- Dyslipidemia, characterized by imbalances in lipid components, is a significant risk factor for cardiovascular diseases, including heart disease and stroke.
- Lipids are transported in plasma as complexes of lipid and proteins known as lipoproteins, including VLDL, LDL, and HDL.
- Commonly used lipid-lowering drugs include HMG-CoA reductase inhibitors (statins), niacin, fibrates, and bile acid–binding resins.
- Statins inhibit HMG-CoA reductase, interfering with cholesterol synthesis, and can cause myalgia, rhabdomyolysis, and increased liver enzymes as adverse effects.
- Fibrates activate nuclear receptors and regulate lipid metabolism, with adverse effects including gastrointestinal upset, diarrhea, and myositis. They also have drug interactions with warfarin and other medications.
Test your knowledge of anticoagulants, thrombolytics, and lipid-lowering drugs with this quiz. Explore the mechanisms, therapeutic uses, and adverse effects of these medications, as well as their role in managing cardiovascular diseases and dyslipidemia.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
